Saccharomyces cerevisiae metabolic engineering services offer advanced solutions for optimizing the metabolic pathways of this widely used yeast species to enhance the production of valuable biochemicals, biofuels, pharmaceuticals, and other industrially relevant products. Our comprehensive services provide support from initial project design to final strain optimization, ensuring precise and efficient metabolic modifications tailored to your specific research and biotechnological needs.
Construction of yeast strains for simultaneous utilization of lignocellulosic sugars (J Lian, et al.,2018)
Saccharomyces cerevisiae, commonly known as baker's yeast, is a model organism extensively used in genetics, molecular biology, and biotechnology. Its ease of genetic manipulation, well-characterized genome, and ability to thrive in various industrial processes make it an ideal system for metabolic engineering. Our services leverage advanced genetic engineering techniques, including CRISPR/Cas9, homologous recombination, and synthetic biology approaches, to deliver high-quality engineered yeast strains.
The applications of Saccharomyces cerevisiae metabolic engineering are diverse and impactful, including:
The process of Saccharomyces cerevisiae metabolic engineering involves several critical and interrelated steps:
For more information about our Saccharomyces cerevisiae Metabolic Engineering Services or to discuss your specific needs, please contact us. Our team of experts is available to provide guidance and support for your research and biotechnological projects, ensuring you achieve your scientific and industrial goals.
The following table provides an overview of various case studies in Saccharomyces cerevisiae metabolic engineering and the solutions we offer to support your research and biotechnological endeavors:
Case Study | Description | Solutions We Offer |
---|---|---|
Ethanol Production Optimization | Engineering yeast strains to enhance ethanol production from biomass. | Pathway design, genetic modification, strain optimization, and scale-up. |
Antibiotic Production Enhancement | Modifying metabolic pathways to increase the yield of antibiotics. | CRISPR/Cas9 gene editing, pathway optimization, and production scaling. |
Organic Acid Production | Developing strains for the efficient production of organic acids for industrial use. | Metabolic pathway reconstruction, strain engineering, and yield optimization. |
Biofuel Production Strains | Optimizing metabolic pathways for the efficient production of biofuels. | Gene pathway engineering, strain development, and production optimization. |
Industrial Biochemical Synthesis | Engineering yeast to produce solvents and other industrial biochemicals. | Synthetic biology, pathway integration, and functional assays. |
Synthetic Pathway Construction | Constructing synthetic pathways in yeast for the production of novel biochemicals. | Synthetic biology, pathway integration, and functional assays. |
Saccharomyces cerevisiae was engineered with an n-butanol biosynthetic pathway, in which isozymes from a number of different organisms (S. cerevisiae, Escherichia coli, Clostridium beijerinckii, and Ralstonia eutropha) were substituted for the Clostridial enzymes and their effect on n-butanol production was compared. By choosing the appropriate isozymes, we were able to improve production of n-butanol ten-fold to 2.5 mg/L. The most productive strains harbored the C. beijerinckii 3-hydroxybutyryl-CoA dehydrogenase, which uses NADH as a co-factor, rather than the R. eutropha isozyme, which uses NADPH, and the acetoacetyl-CoA transferase from S. cerevisiae or E. coli rather than that from R. eutropha. Surprisingly, expression of the genes encoding the butyryl-CoA dehydrogenase from C. beijerinckii (bcd and etfAB) did not improve butanol production significantly as previously reported in E. coli. Using metabolite analysis, we were able to determine which steps in the n-butanol biosynthetic pathway were the most problematic and ripe for future improvement.
n-Butanol production from engineered S. cerevisiae (EJ Steen, et al.,2008)
Symbols and strains: black squares, ESY7; empty squares, ESY11; black circles, ESY2; the rest of the samples all produced approximately the same amount of n-butanol and are indicated on the graph. Symbols and error bars represent the mean and standard deviation of triplicate cultures.
n-Butanol pathway intermediates at 24 h (EJ Steen, et al.,2008)
Bars and strains: black bars, ESY4; gray bars, ESY7; white bars, ESY11. (A) All pathway intermediates in strains ESY4, 7 and 11. (B) HbCoA, CrCoA and BtCoA intermediates in strains ESY4 and ESY7. Levels of AcCoA were similar except for strains ESY11 (A). Levels of 3-hydroxybutyryl-CoA (HbCoA) and butyryl-CoA (BtCoA) were notably higher in ESY7 compared to ESY4, while crotonyl-CoA (CrCoA) was relatively similar in the two strains. Values and error bars represent the mean and standard deviation of triplicate cultures.
A: Saccharomyces cerevisiae metabolic engineering involves the genetic modification of yeast strains to optimize their metabolic pathways for the production of target compounds. This can include introducing, deleting, or modifying specific genes to redirect metabolic fluxes and increase the yield of desired products.
A: Saccharomyces cerevisiae metabolic engineering is performed through a series of steps including project consultation, pathway analysis and design, vector design and construction, yeast transformation, selection and screening, strain optimization, characterization and validation, scale-up and production, and reporting. Each step ensures precise and efficient metabolic modifications.
A: Applications include biofuel production, pharmaceutical production, industrial biochemicals production, food and beverage industry, synthetic biology, and agricultural biotechnology. Engineered yeast strains are used to produce valuable bioproducts and address various industrial and environmental challenges.
A: Key steps include project consultation, pathway analysis and design, vector design and construction, yeast transformation, selection and screening, strain optimization, characterization and validation, scale-up and production, and reporting. These steps ensure comprehensive and accurate development of engineered yeast strains.
A: Saccharomyces cerevisiae metabolic engineering is important for advancing research, developing new bioproducts, optimizing industrial processes, and addressing environmental challenges. Engineered yeast strains provide valuable tools for enhancing production yields and creating novel compounds.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.